To determine the potential of haptoglobin as a serological biomarker for NSCLC, we analyzed the levels of serum haptoglobin in NSCLC patients and normal healthy controls by turbidimetric immunoassay. The gene discussed is HP; the disease is non-small cell lung carcinoma.